<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>56</patient-age><report-id>PHEH2012US025246</report-id><gender>female</gender><reactions><reaction>Patient became hypotensive / diastolic blood pressure was 65</reaction><reaction>Dizziness</reaction><reaction>Leg pain</reaction><reaction>Medication is not working</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>GILENYA</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>COREG</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>HYDROCODONE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>HYDROXYZINE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PROVIGIL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>LYRICA</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ARICEPT</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CYMBALTA</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>XANAX</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>RESTORIL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>HYDROCHLOROTHIAZIDE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ACTHAR</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>NORCO</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>VIT D</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Multiple sclerosis</indication></indications><outcomes><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4149691_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125152631</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>5</safetyreportversion>
		<safetyreportid>PHEH2012US025246</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-12-21</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-22</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHEH2012US025246</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportergivename>Bennett</reportergivename>
			<reporterfamilyname>Myers</reporterfamilyname>
			<reporterstreet>3980 Sheridan Dr. Suite 200</reporterstreet>
			<reportercity>Amherst</reportercity>
			<reporterstate>NY</reporterstate>
			<reporterpostcode>14226</reporterpostcode>
			<reportercountry>US</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>SB</patientinitial>
			<patientbirthdateformat>102</patientbirthdateformat>
			<patientbirthdate>19560715</patientbirthdate>
			<patientweight>61.224</patientweight>
			<patientheight>163</patientheight>
			<patientsex code="2">Female</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Myopathy</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Insomnia</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Arthralgia</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Pelvic pain</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Pain in extremity</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Back pain</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Malaise</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Fatigue</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Amnesia</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Hypertension</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Anxiety</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Patient became hypotensive / diastolic blood pressure was 65</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Hypotensive</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Hypotension</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20121221</reactionstartdate>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Dizziness</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Dizziness</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Dizziness</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20121221</reactionstartdate>
				<reactionfirsttime>1</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Leg pain</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Leg pain</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Pain in extremity</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20121221</reactionstartdate>
				<reactionfirsttime>1</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Medication is not working</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Drug ineffective</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Drug ineffective</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121221</testdate>
				<testname>Blood pressure diastolic</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121221</testdate>
				<testname>Heart rate</testname>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>GILENYA</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>22-527</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>0.5 mg, QD</drugdosagetext>
				<drugdosageform normalized="capsule">Capsule</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Multiple sclerosis</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-12-21</drugstartdate>
				<actiondrug code="4">Dose not changed</actiondrug>
				<drugadditional code="ExpDT=31-MAR-2013"/>
				<activesubstance>
					<activesubstancename>FINGOLIMOD</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dizziness</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dizziness</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Drug ineffective</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypotension</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypotension</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pain in extremity</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Pain in extremity</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>COREG</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>6.25</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>6.25 mg, BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CARVEDILOL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>COREG</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>12.5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>12.5 mg BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CARVEDILOL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>HYDROCODONE</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugdosagetext>UNK UKN, UNK</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>HYDROCODONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>HYDROXYZINE</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>25</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>3</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>25 mg, TID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>HYDROXYZINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>PROVIGIL</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>200</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>200 mg, QD (morning)</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>MODAFINIL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>LYRICA</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>100</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>3</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>100 mg, TID</drugdosagetext>
				<drugdosageform normalized="capsule">Capsule</drugdosageform>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>PREGABALIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ARICEPT</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>10</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>10 mg, QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>DONEPEZIL HYDROCHLORIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ARICEPT</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>100</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>100 mg, QHS</drugdosagetext>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>DONEPEZIL HYDROCHLORIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CYMBALTA</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>120</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>120 mg, QD</drugdosagetext>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DULOXETINE HYDROCHLORIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CYMBALTA</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>60</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>60 mg QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DULOXETINE HYDROCHLORIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>XANAX</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>.5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>0.5 mg, BID (PRN)</drugdosagetext>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>ALPRAZOLAM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>RESTORIL</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>30</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>30 mg, QHS</drugdosagetext>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>TEMAZEPAM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>HYDROCHLOROTHIAZIDE</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>25</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>25 mg, QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>HYDROCHLOROTHIAZIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ACTHAR</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugdosagetext>80 U/mlPRN</drugdosagetext>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>CORTICOTROPIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>NORCO</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>1</drugstructuredosagenumb>
				<drugstructuredosageunit code="032"/>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>325-7.5 mg QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>HYDROCODONE BITARTRATE, PARACETAMOL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>VIT D</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugstructuredosagenumb>2000</drugstructuredosagenumb>
				<drugstructuredosageunit code="025"/>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>2000 IU, QD</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>ERGOCALCIFEROL</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHEH2012US025246, is a combined spontaneous <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>report received from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>via patient oriented program <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>support program and patient oriented program <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>first dose observation program on 21 Dec 2012 and 22 Dec 2012 and follow up report received from other healthcare <Semaphore x="2425040" class="Occupation" value="Professional Occupation" score="1.00" ID="C75558">professional </Semaphore>via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>support program on 03 Jan 2013 and follow up report received from consumer via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>support program on 04 Jan 2013 and follow up report received from the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 18 Jan 2013 and follow up report received from the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 22 Jan 2013: This is also a quality complaint report (AQWA: 645542). This report refers to a 56-year old, non <Semaphore x="3201094" class="MedDRA LLT" value="Pregnancy" score="1.00" ID="10036556">pregnant</Semaphore>, female patient. The patient's medical history included <Semaphore x="3121475" class="MedDRA LLT" value="Myopathy" score="1.00" ID="10028641"><Semaphore x="2254812" class="Disease or Finding" value="Myopathy" score="1.00" ID="C101216">myopathy </Semaphore>(unspecified)<Semaphore x="1547282" class="Disease or Finding" value="Arthralgia" score="1.00" ID="C50464">, </Semaphore></Semaphore>
    <Semaphore x="2083433" class="AnatomicStructure" value="Joint" score="1.00" ID="C13044">
     <Semaphore x="1563583" class="Disease or Finding" value="Bacterial Arthritis" score="0.76" ID="C26699">
      <Semaphore x="1547603" class="Disease or Finding" value="Arthropathy" score="1.00" ID="C35760">
       <Semaphore x="1547553" class="Disease or Finding" value="Arthrogryposis" score="1.00" ID="C84572">
        <Semaphore x="1547538" class="Procedure" value="Arthrodesis" score="1.00" ID="C52007">
         <Semaphore x="1547427" class="Disease or Finding" value="Arthritis" score="1.00" ID="C2883">
          <Semaphore x="1547407" class="Disease or Finding" value="Arthritis or Polyarthritis due to Streptococcus" score="1.00" ID="C27075">
           <Semaphore x="1547386" class="Disease or Finding" value="Arthritis or Polyarthritis due to Staphylococcus" score="1.00" ID="C27163">
            <Semaphore x="1547366" class="Disease or Finding" value="Arthritis or Polyarthritis due to Pseudomonas" score="1.00" ID="C27077">
             <Semaphore x="1547346" class="Disease or Finding" value="Arthritis or Polyarthritis due to Pneumococcus" score="1.00" ID="C27074">
              <Semaphore x="1547325" class="Disease or Finding" value="Arthritis or Polyarthritis due to Escherichia Coli" score="1.00" ID="C27078">
               <Semaphore x="1547282" class="Disease or Finding" value="Arthralgia" score="1.00" ID="C50464"><Semaphore x="2059169" class="Disease or Finding" value="Insomnia due to Organic Factor" score="1.00" ID="C35647">insomnia</Semaphore><Semaphore x="2083433" class="AnatomicStructure" value="Joint" score="1.00" ID="C13044"><Semaphore x="1563583" class="Disease or Finding" value="Bacterial Arthritis" score="0.76" ID="C26699"><Semaphore x="1547603" class="Disease or Finding" value="Arthropathy" score="1.00" ID="C35760"><Semaphore x="1547553" class="Disease or Finding" value="Arthrogryposis" score="1.00" ID="C84572"><Semaphore x="1547538" class="Procedure" value="Arthrodesis" score="1.00" ID="C52007"><Semaphore x="1547427" class="Disease or Finding" value="Arthritis" score="1.00" ID="C2883"><Semaphore x="1547407" class="Disease or Finding" value="Arthritis or Polyarthritis due to Streptococcus" score="1.00" ID="C27075"><Semaphore x="1547386" class="Disease or Finding" value="Arthritis or Polyarthritis due to Staphylococcus" score="1.00" ID="C27163"><Semaphore x="1547366" class="Disease or Finding" value="Arthritis or Polyarthritis due to Pseudomonas" score="1.00" ID="C27077"><Semaphore x="1547346" class="Disease or Finding" value="Arthritis or Polyarthritis due to Pneumococcus" score="1.00" ID="C27074"><Semaphore x="1547325" class="Disease or Finding" value="Arthritis or Polyarthritis due to Escherichia Coli" score="1.00" ID="C27078"><Semaphore x="1547282" class="Disease or Finding" value="Arthralgia" score="1.00" ID="C50464">, <Semaphore x="2761150" class="MedDRA LLT" value="Arthralgia" score="1.00" ID="10003239">pain in <Semaphore x="1547603" class="Disease or Finding" value="Arthropathy" score="1.00" ID="C35760">joint</Semaphore></Semaphore></Semaphore>
                           <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                            </Semaphore></Semaphore>
                          <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                           </Semaphore></Semaphore>
                         <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                          </Semaphore></Semaphore>
                        <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                         </Semaphore></Semaphore>
                       <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                        </Semaphore></Semaphore>
                      <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                       </Semaphore></Semaphore>
                     <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                      </Semaphore></Semaphore>
                    <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                     </Semaphore></Semaphore>
                   <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                    </Semaphore></Semaphore>
                  <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                   </Semaphore></Semaphore>
                 <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                  </Semaphore></Semaphore>
                <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                 <Semaphore x="2383617" class="Disease or Finding" value="Pelvic Pain" score="1.00" ID="C40122">, </Semaphore></Semaphore></Semaphore>
               <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
                </Semaphore></Semaphore>
              <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
               </Semaphore></Semaphore>
             <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
              </Semaphore></Semaphore>
            <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
             </Semaphore></Semaphore>
           <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
            </Semaphore></Semaphore>
          <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
           </Semaphore></Semaphore>
         <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
          </Semaphore></Semaphore>
        <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
         </Semaphore></Semaphore>
       <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
        </Semaphore></Semaphore>
      <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
       </Semaphore></Semaphore>
     <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
      </Semaphore></Semaphore>
    <Semaphore x="3176563" class="MedDRA LLT" value="Pelvic pain" score="1.00" ID="10034263">
     <Semaphore x="2383651" class="AnatomicStructure" value="Pelvis" score="1.00" ID="C12767">pelvic </Semaphore>
     </Semaphore>
    <Semaphore x="2383651" class="AnatomicStructure" value="Pelvis" score="1.00" ID="C12767">region </Semaphore>and <Semaphore x="2612811" class="AnatomicStructure" value="Thigh" score="1.00" ID="C33763">thigh</Semaphore>, <Semaphore x="1563437" class="Disease or Finding" value="Back Pain" score="1.00" ID="C41830">back pain </Semaphore>(postural), other <Semaphore x="2150758" class="Disease or Finding" value="Malaise" score="1.00" ID="C3832">malaise</Semaphore>, <Semaphore x="1926717" class="Disease or Finding" value="Fatigue" score="1.00" ID="C3036">fatigue </Semaphore>and <Semaphore x="2731662" class="MedDRA LLT" value="Amnesia" score="1.00" ID="10001949">memory loss</Semaphore>. The patient's <Semaphore x="1875899" class="Disease or Finding" value="Electrical Exposure" score="1.00" ID="C45407">current </Semaphore>condition included <Semaphore x="1607320" class="Disease or Finding" value="Blood Pressure Finding" score="1.00" ID="C54707">hypertension </Semaphore>and <Semaphore x="1534652" class="Disease or Finding" value="Anxiety Disorder" score="1.00" ID="C2878">anxiety</Semaphore>. The concomitant medication of the patient included <Semaphore x="407367" class="Medicine" value="Coreg" score="0.49" ID="247880">Coreg </Semaphore>(<Semaphore x="309609" class="Medicine" value="carvedilol" score="0.49" ID="241573">carvedilol</Semaphore>), <Semaphore x="676355" class="Medicine" value="HYDROcodone" score="0.49" ID="270906">hydrocodone</Semaphore>, <Semaphore x="688022" class="Medicine" value="hydrOXYzine" score="0.49" ID="270942">hydroxyzine</Semaphore>, <Semaphore x="1098640" class="Medicine" value="Provigil" score="0.49" ID="248828">Provigil </Semaphore>(<Semaphore x="880060" class="Medicine" value="modafinil" score="0.49" ID="243148">modafinil</Semaphore>), <Semaphore x="804590" class="Medicine" value="Lyrica" score="0.49" ID="275868">Lyrica </Semaphore>(<Semaphore x="1082033" class="Medicine" value="pregabalin" score="0.49" ID="239993">pregabalin</Semaphore>), <Semaphore x="131739" class="Medicine" value="Aricept" score="0.49" ID="227612">Aricept </Semaphore>(<Semaphore x="505446" class="Medicine" value="Donepezil hydrochloride" score="0.49" ID="249826">donepezil hydrochloride</Semaphore>), <Semaphore x="1130041" class="Medicine" value="Restoril" score="0.49" ID="248853">Restoril </Semaphore>(<Semaphore x="1251498" class="Medicine" value="Temazepam" score="0.49" ID="187227">temazepam</Semaphore>), <Semaphore x="423955" class="Medicine" value="Cymbalta" score="0.49" ID="269405">Cymbalta </Semaphore>(<Semaphore x="511454" class="Medicine" value="DULoxetine hydrochloride" score="0.49" ID="269173">duloxetine hydrochloride</Semaphore>), <Semaphore x="1366502" class="Medicine" value="Xanax" score="0.49" ID="241256">Xanax </Semaphore>(<Semaphore x="86364" class="Medicine" value="ALPRAZolam" score="0.49" ID="275883">alprazolam</Semaphore>), hydrochlorthiazide, <Semaphore x="43054" class="Medicine" value="Acthar" score="0.49" ID="188149">Acthar </Semaphore>(<Semaphore x="410005" class="Medicine" value="Corticotropin" score="0.49" ID="264446">corticotropin</Semaphore>), <Semaphore x="931831" class="Medicine" value="Norco" score="0.49" ID="248698">Norco </Semaphore>(<Semaphore x="675986" class="Medicine" value="HYDROcodone Bitartrate" score="0.49" ID="233590"><Semaphore x="2035436" class="Procedure" value="Hydrocodone Measurement" score="1.00" ID="C74879">hydrocodone </Semaphore>bitartrate</Semaphore>, <Semaphore x="2737985" class="MedDRA LLT" value="Analgesic drug level" score="1.00" ID="10060090">paracetamol</Semaphore>) and <Semaphore x="1346638" class="Medicine" value="Vitamin D" score="0.49" ID="196852"><Semaphore x="2692307" class="Procedure" value="Vitamin D Measurement" score="1.00" ID="C84818">Vitamin D </Semaphore>(<Semaphore x="537604" class="Medicine" value="Ergocalciferol" score="0.49" ID="267015">ergocalciferol</Semaphore>). </Semaphore>On 21 Dec 2012, the baseline <Semaphore x="2995451" class="MedDRA LLT" value="Heart rate" score="1.00" ID="10019299"><Semaphore x="2010398" class="AnatomicStructure" value="Heart" score="1.00" ID="C12727">heart </Semaphore>rate </Semaphore>(<Semaphore x="2010261" class="Disease or Finding" value="Heart Rate Score" score="1.00" ID="C81309">HR</Semaphore>) of the patient was 88 <Semaphore x="1587606" class="Procedure" value="Bilateral Prophylactic Mastectomy" score="1.00" ID="C46072">bpm </Semaphore>(beats per minute) at 12: 10 <Semaphore x="2367362" class="Race" value="Panamint" score="1.00" ID="C44560">PM</Semaphore>. This patient received <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>(<Semaphore x="576789" class="Medicine" value="fingolimod" score="0.49" ID="186392">fingolimod</Semaphore>) (Exp. Date: 31 Mar 2013) on 21 Dec 2012 at 12: 30 <Semaphore x="2367362" class="Race" value="Panamint" score="1.00" ID="C44560">PM </Semaphore>at a dose of 0.5 mg once daily for <Semaphore x="2245768" class="Disease or Finding" value="Multiple Sclerosis" score="1.00" ID="C3243">multiple sclerosis</Semaphore>. The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>reported that after the patient had taken the first dose of <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya</Semaphore>, she became symptomatic. The patient became <Semaphore x="3023386" class="MedDRA LLT" value="Hypotension" score="1.00" ID="10021097">hypotensive </Semaphore>without <Semaphore x="1626609" class="Disease or Finding" value="Bradycardia" score="1.00" ID="C37920">bradycardia </Semaphore>and at that point, it was about five hours into first dose observation (FDO). The patient had a <Semaphore x="2815388" class="MedDRA LLT" value="Blood pressure diastolic decreased" score="1.00" ID="10005737">decrease in <Semaphore x="1847843" class="Disease or Finding" value="Diastolic Dysfunction" score="1.00" ID="C79547">diastolic </Semaphore><Semaphore x="1607320" class="Disease or Finding" value="Blood Pressure Finding" score="1.00" ID="C54707">blood pressure </Semaphore></Semaphore>(<Semaphore x="1607320" class="Disease or Finding" value="Blood Pressure Finding" score="1.00" ID="C54707">BP</Semaphore>) to 65 (unit <Semaphore x="2665498" class="AnatomicStructure" value="Unspecified Anatomic Sites" score="1.00" ID="C13411">not specified</Semaphore>). The patient's minimum <Semaphore x="2010261" class="Disease or Finding" value="Heart Rate Score" score="1.00" ID="C81309">HR </Semaphore>was 64 <Semaphore x="1587606" class="Procedure" value="Bilateral Prophylactic Mastectomy" score="1.00" ID="C46072">bpm </Semaphore>during the FDO and it took five hours to reach this value from the first dose of <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya</Semaphore>. The patient also <Semaphore x="2005619" class="Procedure" value="Have Pain" score="1.00" ID="C91126">had <Semaphore x="2102828" class="Disease or Finding" value="Leg Pain" score="1.00" ID="C34764">leg pain </Semaphore></Semaphore>and <Semaphore x="1861243" class="Disease or Finding" value="Dizziness" score="1.00" ID="C37943">dizziness</Semaphore>. The patient was treated with intravenous (IV) 1000 ml <Semaphore x="2763866" class="MedDRA LLT" value="Aspartate aminotransferase normal" score="1.00" ID="10003482"><Semaphore x="933272" class="Medicine" value="Normal saline" score="0.49" ID="216804">normal saline </Semaphore>to get </Semaphore><Semaphore x="1847843" class="Disease or Finding" value="Diastolic Dysfunction" score="1.00" ID="C79547">diastolic </Semaphore><Semaphore x="1607320" class="Disease or Finding" value="Blood Pressure Finding" score="1.00" ID="C54707">BP </Semaphore>higher but no changes were observed. The patient's MD advised that the patient should go to the <Semaphore x="1887644" class="AnatomicStructure" value="Endoplasmic Reticulum" score="1.00" ID="C13230">ER </Semaphore>(emergency room) and have a 23 hour observation period. The patient had an <Semaphore x="1877067" class="Procedure" value="Electrocardiography" score="1.00" ID="C38053">ECG </Semaphore>(<Semaphore x="1877067" class="Procedure" value="Electrocardiography" score="1.00" ID="C38053">electrocardiogram</Semaphore>) and <Semaphore x="2817940" class="MedDRA LLT" value="Blood test" score="1.00" ID="10061726"><Semaphore x="2013340" class="Procedure" value="Hematology Test" score="1.00" ID="C49286">blood <Semaphore x="1787567" class="Disease or Finding" value="Clinical Test Result" score="1.00" ID="C77140">tests </Semaphore></Semaphore>
     <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">
      </Semaphore></Semaphore>
    <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">
     <Semaphore x="1787567" class="Disease or Finding" value="Clinical Test Result" score="1.00" ID="C77140">(result </Semaphore></Semaphore>and date unspecified) done. The patient was admitted to the local hospital and discharged on the same day. The patient further confirmed that she was down to her last 5 pills. The patient also asked how long it would take for the medication to work because it was not working for her. <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">Treatment </Semaphore>with <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>was ongoing. The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>assessed the events as serious. <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">Outcome </Semaphore>of the event <Semaphore x="1607320" class="Disease or Finding" value="Blood Pressure Finding" score="1.00" ID="C54707">hypotension </Semaphore>was reported as recovered on the same day and for the other events was not reported. The causality of the events was not reported.Follow up report received from other healthcare <Semaphore x="2425040" class="Occupation" value="Professional Occupation" score="1.00" ID="C75558">professional </Semaphore>via patient oriented program <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>support program on 03 Jan 2013. Reporter and information regarding <Semaphore x="3012166" class="MedDRA LLT" value="Hospitalisation" score="1.00" ID="10054112">hospitalization </Semaphore>were updated.Follow up report received from consumer via <Semaphore x="619905" class="Medicine" value="Gilenya" score="1.00" ID="186396">Gilenya </Semaphore>support program on 04 Jan 2013: Information related to new event (medication was not working) was updated.Follow up report received from the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 18 Jan 2013: Information related to medical history, concomitant medications and <Semaphore x="3012166" class="MedDRA LLT" value="Hospitalisation" score="1.00" ID="10054112">hospitalization </Semaphore>details were updated.Follow up report received from the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 22 Jan 2013: Information regarding <Semaphore x="1875899" class="Disease or Finding" value="Electrical Exposure" score="1.00" ID="C45407">current </Semaphore>condition, dosage of concomitant medications and details of FDO was updated.</narrativeincludeclinical>
				<sendercomment>Medic Comment: The available reported data does not allow for a proper causality assessment. The case has been conservatively assessed as suspected and will be reassessed after the availability of follow up</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>